PHASE-I STUDY OF ANTILIPOPOLYSACCHARIDE HUMAN MONOCLONAL-ANTIBODY MAB-T88

被引：12

作者：

DAIFUKU, R ^{[1
]}

HAENFTLING, K ^{[1
]}

YOUNG, J ^{[1
]}

GROVES, ES ^{[1
]}

TURRELL, C ^{[1
]}

MEYERS, FJ ^{[1
]}

机构：

[1] CHIRON CORP,1400 53RD ST,EMERYVILLE,CA 94608

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1992年 / 36卷 / 10期

关键词：

D O I：

10.1128/AAC.36.10.2349

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Monoclonal antibody MAB-T88 is a human monoclonal immunoglobulin M antibody directed at the lipopolysaccharide of gram-negative bacteria. In this study, nine patients who were expected to become neutropenic from antineoplastic chemotherapy received an infusion of MAB-T88, three patients at each of three doses: 1, 4, and 8 mg/kg of body weight. MAB-T88 was shown to be safe, with an effective half-life in plasma of 25.4 h, and no patient developed immunoglobulin G antibody to MAB-T88.

引用

页码：2349 / 2351

页数：3

共 50 条

[31] Phase I study of CNTO 95, a fully human monoclonal antibody (mAb) to αv integrins, in patients with solid tumors
Jayson, Gordon C.
Mullamitha, S.
Ton, C.
Valle, J.
Saunders, M.
Munteanu, M. C.
Jiao, Q.
Davis, H. M.
Lang, Z.
Beckman, R. A.
[J]. ANNALS OF ONCOLOGY, 2004, 15 : 102 - 102
[32] Phase I study of CNTO 95, a fully human monoclonal antibody (mAb) to αv integrins, in patients with solid tumors
Jayson, GC
Mullamitha, S
Ton, C
Valle, J
Saunders, M
Munteanu, MC
Jang, H
Trikha, M
Davis, HM
Beckman, RA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 224S - 224S
[33] Phase I study of CNTO 95, a fully human monoclonal antibody (mAb) to αv integrins, in patients with solid tumors
Jayson, GC
Mullamitha, S
Ton, C
Valle, J
Jackson, A
Julyan, P
Munteanu, MC
Davis, HM
Lang, Z
Beckman, RA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 220S - 220S
[34] INDIUM-111-LABELED B72.3 MONOCLONAL-ANTIBODY IN THE DETECTION AND STAGING OF BREAST-CANCER - A PHASE-I STUDY
LAMKI, LM
BUZDAR, AU
SINGLETARY, SE
ROSENBLUM, MG
BHADKAMKAR, V
ESPARZA, L
PODOLOFF, DA
ZUKIWSKI, A
HORTOBAGYI, GN
MURRAY, JL
[J]. JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (07) : 1326 - 1332
[35] PHASE-I STUDY OF MONOCLONAL-ANTIBODY RICIN-A CHAIN IMMUNOCONJUGATE XOMAZYME-791 IN PATIENTS WITH METASTATIC COLON-CANCER
LORUSSO, PM
LOMEN, PL
REDMAN, BG
POPLIN, E
BANDER, JJ
VALDIVIESO, M
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (04): : 307 - 312
[36] GENERATION AND CHARACTERIZATION OF A NOVEL MONOCLONAL-ANTIBODY (MAB) ASSOCIATED WITH A HUMAN METASTATIC MELANOMA ANTIGEN
TREFZER, U
GELLRICH, S
GUO, YJ
SY, MS
STERRY, W
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (03) : 490 - 490
[37] DETERMINATION OF THE FINE SPECIFICITY OF A MONOCLONAL-ANTIBODY (MAB) TO A HUMAN T-CELL RECEPTOR (TCR) V-REGION
KEEGAN, M
RITTERSHAUS, C
KUBINEC, J
JANSON, C
JONES, N
[J]. FASEB JOURNAL, 1991, 5 (04) : A615 - A615
[38] MOUSE MONOCLONAL-ANTIBODY DETECTING GP3 GANGLIOSIDE - A PHASE-I TRIAL IN PATIENTS WITH MALIGNANT-MELANOMA
HOUGHTON, AN
VADHANRAJ, S
CORDONCARDO, C
WELT, S
MINTZER, D
FLIEGEL, B
CARSWELL, E
MELAMED, MR
OETTGEN, HF
OLD, LJ
[J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 284 - 284
[39] A PHASE-I CLINICAL-TRIAL OF MURINE MONOCLONAL-ANTIBODY D612 IN PATIENTS WITH METASTATIC GASTROINTESTINAL CANCER
SALEH, MN
KHAZAELI, MB
GRIZZLE, WE
WHEELER, RH
LAWSON, S
LIU, TP
RUSSELL, C
MEREDITH, R
SCHLOM, J
LOBUGLIO, AF
[J]. CANCER RESEARCH, 1993, 53 (19) : 4555 - 4562
[40] PHASE-I EVALUATION OF A COMBINATION OF MONOCLONAL-ANTIBODY R24 AND INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA
BAJORIN, DF
CHAPMAN, PB
WONG, G
COIT, DG
KUNICKA, J
DIMAGGIO, J
CORDONCARDO, C
URMACHER, C
DANTES, L
TEMPLETON, MA
LIU, J
OETTGEN, HF
HOUGHTON, AN
[J]. CANCER RESEARCH, 1990, 50 (23) : 7490 - 7495

← 1 2 3 4 5 →